Moderate Aortic Stenosis: Pathophysiology, Diagnostic Criteria, Prognosis and Evolving Management
Aortic stenosis (AS) is a progressive valvular disease with rising incidence, particularly among elderly populations. Although excess mortality in severe AS is well recognised, moderate AS is also associated with significant morbidity and mortality. Current guidelines recommend valve replacement only for severe AS or in moderate AS with a concomitant surgical indication, leaving a therapeutic gap. This review summarises current knowledge on the epidemiology, pathophysiology, natural history and diagnostic challenges of AS management, with an emphasis on moderate disease. We discuss prognostic markers, including myocardial fibrosis, reduced left ventricular ejection fraction, global longitudinal strain and autonomic dysfunction, that may identify high-risk moderate AS patients. Evidence from recent and ongoing trials of transcatheter aortic valve replacement and novel pharmacotherapies is summarised, and limitations of existing valve prostheses and medical therapies are discussed. Improved risk stratification, earlier detection of pathological changes and targeted intervention may ultimately improve the management paradigm for moderate AS.
Authors
- Andrew O Maree (ORCID: https://orcid.org/0000-0002-0002-5828)
- Rose Anne Kenny (ORCID: https://orcid.org/0000-0002-9336-8124)
- Mark Hensey (ORCID: https://orcid.org/0000-0001-9270-6446)
- Jack Hartnett (ORCID: https://orcid.org/0000-0001-8066-1914)
- Caroline Daly (ORCID: https://orcid.org/0000-0002-5994-3279)
- Niall Patrick Connolly (ORCID: https://orcid.org/0000-0002-1493-6454)
- Stephen O’Connor
Institutions
- Trinity College Dublin (IE)
- St. James's Hospital (IE)
Publication Details
- Journal
- European Cardiology Review
- Published
- 2026-11-16
- DOI
- https://doi.org/10.15420/ecr.2025.78
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00